°¥£¬ÎÒ¸úÄ㽲ࣣ¬¹ãÖÝÀóÍåÇøÄÇ¿éµØ·½Å¶£¬²Ø×Ų»ÉٺóԺÃÍæµÄ°å·¡£ÄãÏþµÃû£¬ÓÐЩ½ÖµÀÃû×ÖÌýÆð¾ÍÂùÓÐÒâ˼£¬ºÃ±ÈÓеĵط½Ö±½ÓÓÃÍâµØÌØÉ«ÃüÃû£¬ÏñÊǼ¦½ÖÕâÖÖ¡£ÎÒ¹À¶ÑÐí¶àÈ˶¼ºÃÆæ£¬Õ⼦½Ö¾¿¾¹¸ü×ÓÀ´µÄ£¿Ãû×Ö±³ºóÊDz»ÊÇÁíÓеã¹ÊÊ£¿½ñÌìÎÒÃǾÍÀ´³¶³¶ÀóÍåÇøµÄСºúͬ¼¦½Ö£¬Þß¿¾¿¾¹½Ðɶ£¬½²Î´±ØÄ㻹ÄÜ·¢Ã÷µãÐÂÏʰåÂ·ÄØ¡£
ÀóÍåÇøÐ¡ºúͬ¼¦½ÖµÄÃû×ÖÀ´Àú
Õâô¸úÄã½²¿©£¬ÀóÍåÇøÐ¡ºúͬ¼¦½ÖÆäʵÂùÓÐȤµÄ¡£ËüÃû×ֽм¦½Ö£¬ÓÐÈËÒ»Ìý¾ÍÒÔΪÊÇÂô¼¦µÄµØ·½£¬ÆäʵÞß¿Ö÷ÒªÊDzÍÒûÒ»Ìõ½Ö£¬ÓÈÆäÒÔ¼¦µÄÖÖÖÖ×ö·¨×ÅÃû¡£Ïñ°×Çм¦¡¢ÉÕ¼¦ÕâЩ£¬ÏÕЩÊǼҼҶ¼ÓеÄÕÐÅÆ²Ë¡£ÎÒ´ÓϸÍÞ×оÍÌý˵£¬¼¦½ÖÃû×ÖµÄÓÉÀ´£¬¿ÉÄÜÊÇ×îÔçÄÇ¿Óм¸¼Ò×ö¼¦µÄ¹Ý×Ó£¬ÉúÒâºÃµÃ°å·£¬ÕûÌõ½Ö¶¼Ëæ×ÅÍúÆðÀ´ÁË¡£
½²µ½ÕâÀÄã·¢Ã÷û£¬ÕâÖÖ¡°ÒÔ¼¦ÎªÃû¡±µÄ½ÖµÀ£¬Æäʵ¾ÍÊÇÒ»ÖÖÀϹãÖݵÄÎÄ»¯ÌØÉ«¡£ÓÃʳÎïÀ´±ê¼ÇµØÃû£¬¼È¼òµ¥ÓÖÖ±½Ó¡£Ïñ¹ðÁÖÎÒÃÇÕâ±ßÒ²ÓÐÃ×·Û½Ö£¬¶¼ÊDzîδ¼¸µÄ°å·¡£
ʵÓÃСÌùÊ¿£º¼¦½ÖÔõô¿Ë²»²È¿Ó£¿
ʵÓÃСÌùÊ¿£ºÞß¿µÄ¹Ý×Ӷ࣬¼ÇµÃÑ¡ÄÇЩÃÅ¿ÚÈËÆøÍúµÄ£¬ÓÈÆäÊÇÍâµØÈ˰®È¥µÄµê×Ó£¬Ò»°ãζµÀ¶¼´í²»ÁË¡£ÁíÍ⣬¼°ÔçÈ¥£¬Ã»È»Íí·¹á¯ÁëÈ˼·ÈË£¬ÅŶÓÅŵ½ÄãÏë¡°·¢Ã«¡±¡£
¼¦½ÖµÄÌØÉ«²ËºÍÎÄ»¯Æø·Õ
ÔÙ½²»Ø¼¦½ÖµÄÌØÉ«²Ë£¬ÎÒ¹À¶Ñ×î×ÅÃûµÄÕվɰ×Çм¦£¬ÈâÄ۵ðå·£¬ÕºÉϽª´Ð½´ÓÍ£¬Ë¬ÉñµÃºÜ¡£ÁíÍâÉÕ¼¦Ò²ÊÇÒ»¾ø£¬Æ¤ËÖÈâÏ㣬ҧÉÏÒ»¿Ú¼òֱͣ²»ÁË¡£³ýÁ˼¦£¬Þß¿ÁíÓв»ÉÙÔÁ²ËÉϵÄСµãÐÄ£¬ºÃ±ÈϺ½È¡¢³¦·ÛÕâЩ£¬´îÅäÆðÀ´£¬¼òÖ±¾ÍÊÇÒ»×À×Ó¹ãÖÝζ¡£
³ýÁ˳Ե쬼¦½ÖµÄÎÄ»¯Æø·ÕÒ²ÓеãÒâ˼¡£½ÖµÀ²»¿í£¬Ïï×ÓÀïÍ·¼·ÂúÁËʳ¿Í£¬ÉÌÆÌµÄÕÐÅÆÒ»¸ö°¤Ò»¸ö£¬µÆ×ÆË¸µÃ»ÐÄ£ºý㱡£ÄãÏþµÃû£¬ÓÐʱºò³ÔµÄ²»ÊDzˣ¬ÊÇÕâÖÖÈÈÄÖÆø·Õ£¬Ò»±ßࢼ¦Ò»±ßÌýÀϰåÕкô¿ÍÈË£¬¸ÐÊܳԳöÁËÈËÇéζ¡£
³£¼ûÎóÇø£º¼¦½ÖÖ»³Ô¼¦£¿
³£¼ûÎóÇø£ºÓÐÈËÒÔΪ¼¦½ÖÖ»ÄܳԼ¦£¬ÆäʵÞß¿µÄÔÁ²ËÒ²Âù¸»ºñµÄ£¬Ïñº£ÏÊ¡¢µãÐÄÕâЩ¶¼ÖµµÃÊÔÊÔ¡£Äª¾ÖÏÞÓÚ¼¦£¬Õû×ÀµãÆðÀ´²Å¸üˬÉñ¡£
ÄǾ¿¾¹Òª¸ü×ÓÑ¡²Åû²È¿Ó£¿
ÎÒ¹À¶ÑŶ£¬¼¦½ÖÑ¡¹Ý×ÓÖ÷Òª¿´ÈËÆø£¬Ñ¡ÍâµØÈËÔú¶ÑµÄµØ·½×¼Ã»´í¡£ÔټǵÃÔçµãÈ¥£¬Ã»È»ÅŶÓÅŵ½Í·»è¡£³ÔµÄʱºò±ðÖ»¶¢×ż¦£¬µãµãÆäËûÔÁ²ËºÍСµãÐÄ£¬´îÅäÆðÀ´¸ü°ÍÊÊ¡£
ÀóÍåÇø¼¦½Ö, ¹ãÖÝÃÀʳ½Ö, ¼¦½Ö²Í¹ÝÍÆ¼ö, °×Çм¦, ÔÁ²ËÌØÉ«
¡¶³É¶¼ÄÄÀïÕ¾´ó½Ö×îÄêÇá¡·
ËüÃǵÄÐж¯±êÃ÷£¬Ç¿´óµÄ±¾ÍÁ¹©Ó¦Á´Ðͬ³öº££¬ÎªÖйú¿¨³µÆ·ÅÆÌṩÁ˱¾Ç®¡¢ÏìÓ¦ËٶȺͼ¼Êõ¶¨ÖÆÉÏµÄÆæÌؼ¯ÍžüÓÅÊÆ£¬ÊÇÕû³µ³§ÔÚǰÏß³å·æÊ±×î¿É¿¿µÄ¡°µ¯Ò©ÓëºóÇÚ°ü¹Ü¡±¡£
¡¶ËÄÖÜÍÆÄõê500Ã×ÄÚÓÐÄÄЩ¡·
About U-mab U-mab Biopharma,founded in July2017,is a biotechnology company focused on discovering and developing NOVel First-in-class(FIC)and best-in-class(BIC)biologic therapeutics for oncology and inflammatory diseases.The company received a strategic investment from Tianhui Capital in2021and has established a fully integrated,proprietary platform for early-stage antibody discovery and engineering¡ªenabling the rapid identification and optimization of high-quality therapeutic candidates.Guided by a core Strategy of inNOVation-driven internal RD,U-mab actively pursues strategic collaborations with industry leaders to advance its pipeline toward clinical development.
¡¶ÉîÛÚspa»çËØÒ»ÀÀ±í¡·
ËäÈ»ÌØÀÊÆÕ¹ØÓÚÊÕ¹º¸ñÁêÀ¼µºµÄÑÔÂÛ²¢·ÇÐÂÏÊÊ¡ª¡ª¿É×·ËÝÖÁ2019ÄêËûµÄµÚÒ»¸öÈÎÆÚ¡ª¡ªµ«Æä½üÆÚµÄÑÔÂÛÇ¿¶ÈÓÐËùÉý¼¶£¬²¢Îª×Ô¼ºÉ趨ÁËÁ½µ½ÈýÖܵÄ×îºóÆÚÏÞÒÔÈ¡µÃ½øÕ¹¡£ÕâÖÖÔÙ¶ÈÉýεÄÐж¯ÐźűêÃ÷£¬ÌØÀÊÆÕ¶Ô¸ñÁêÀ¼µØÔÃ÷ÈÕ½ÂÔ¼ÛÖµµÄºã¾ÃÐËȤ£¬ÓëÆäËùÈÏÖªµÄÈ«ÇòÍþв֮¼ä±£´æÒò¹û¹ØÁª¡£